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The concept that secretion of the antidiuretic hor-
mone, arginine vasopressin, is regulated by the os-
molality of body water originated with the pioneering
studies of Verney over 25 years ago [1]. In a classical
series of experiments, this investigator showed that
the injection of hypertonic saline into the carotid
artery of conscious, hydrated dogs resulted in a
prompt and reversible fall in urine output that was
indistinguishable from that produced by the i.v. in-
jection of small amounts of pituitary extract. On the
basis of this and other indirect evidence, Verney con-
cluded that the release of vasopressin from the neu-
rohypophysis was controlled by an intracranial os-
moreceptor that was extremely sensitive to changes in
the blood concentration of sodium and certain other
solutes.
Efforts to confirm and extend these observations
were limited for many years by the lack of a suitable
method for measuring vasopressin directly at the low
concentrations normally present in body fluids. Re-
cently, howe'er, several laboratories have succeeded
in developing sensitive and specific radioimmunoas-
say methods that permit the hormone to be meas-
ured at physiologic concentrations with greater ease
and precision [2,3]. As reviewed in the following
pages, these new assay methods now have made it
possible to begin to characterize osmoregulatory
function in a more concrete and comprehensive way
and also to use such information to analyze system-
atically certain clinical disorders of salt and water
balance.
Normal osmoregulatory function. The functional
characteristics of the osmoreceptor controlling vaso-
pressin secretion can be readily appreciated by exam-
ining the relationship between plasma vasopressin
concentration and plasma osmolality over a suitably
wide range of values. When this is done in a group of
healthy adults (Fig. 1), one discerns a definite pattern
in which plasma vasopressin is suppressed uniformly
to low or undetectable levels below a certain level of
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plasma osmolality. Above this point, however,
plasma vasopressin levels increase steeply in propor-
tion to the increase in plasma osmolality. This kind of
relationship has now been observed by a number of
laboratories using different methods to assay vaso-
pressin in the plasma or urine of men and rats under-
going different kinds of osmotic stress [4—12] and,
hence, would appear to provide a widely applicable
means of characterizing osmoregulatory function.
The advantage of this kind of analysis is that
the major functional properties of the osmoreceptor,
threshold and sensitivity, can be defined quanti-
tatively in terms of the regression line relating these
two variables. Thus, if all the values of Fig. tin which
plasma osmolality is greater than 280 mOsm/kg are
subjected to standard regression analysis, one finds a
highly significant positive correlation between plasma
vasopressin (PAVP) and plasma osmolality (Posm)
that is described by the linear function PAVP = 0.38
Posm —106.4. This can be rearranged to the phys-
iologically more meaningful form, PAVP = 0.38
(Posm —280), which describes the regression line in
terms of its intercept on the x axis instead of the y
axis. This x axis intercept value indicates the level of
plasma osmolality at which osmotically mediated in-
creases in plasma vasopressin begin to appear, and
thus provides a measure of the threshold or "set-
point" of the osmoreceptor mechanism. The values
obtained in this way appear to be quite reproducible
when determined at different times in the same or
similarly composed groups of subjects [4,10,11,13]
and to agree closely with those previously determined
by indirect methods [14]. For example, the value of
280 mOsm/kg obtained in one group of variously
hydrated recumbent adults (Fig. 1) is nearly identical
to the value of 281 mOsm/kg obtained with the same
assay in another group studied under similar condi-
tions [10] and is remarkably close to the mean (±sD)
value of 282.2 2.0 mOsm/kg determined indirectly
by following changes in free water clearance in
healthy adults recovering from an acute water load
[14]. It should be noted that slightly lower mean
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threshold values have been found in smaller immu-
noassay studies from England [5], France [81 and
Japan [9]. Whether this is due simply to method-
ologic differences between the various laboratories or
also reflects genetic or environmental differences be-
tween these populations is still unclear.
The sensitivity of the osmoregulatory mechanism is
reflected in the slope of the regression line relating
plasma vasopressin concentration to plasma osmo-
lality. In one large group of healthy adults this
value averaged 0.38 (Fig. I) and in another group
studied in a similar manner, 0.34 pg/mi per mOsm/
kg [101. This means that for each unit increment in
plasma osmolality above the threshold of the Os-
moreceptor, plasma vasopressin also increases by an
average of about 0.34 pg/mI. Thus, a change in
plasma osmolality of only 1% (2.9 mOsm/kg) would
be expected to change plasma vasopressin by about I
pg/mi, an amount large enough to be detected by
some immunoassays [3,5,9] and to cause relatively
large changes in urinary concentration (Fig. 2). This
result is in full agreement with the estimates of os-
moreceptor sensitivity originally made by Verney us-
ing indirect methods in dogs [11.
The extraordinary sensitivity of this osmoregula-
tory mechanism has a number of important phys-
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Fig. 1. The relationship of plasma vasopressin to plasma osmolality
in healthy adults and patients with dtfferent types of polyuria 131-
I I (
3 4 5 10
Plasma AVP, pg/mi
Fig. 2. The relationship of urine osmolality to plasma vasopressin in
healthy adults and patients with dffereng types of polyuria [3].
iologic and methodologic implications which can
be fully appreciated only by examining the rela-
tionship between plasma vasopressin concentration
and urine osmolality. When this is done in a large
group of variously hydrated healthy adults (Fig. 2),
one observes that despite considerable variation in
solute excretion rate, there is a highly significant posi-
tive correlation between these two variables that can
- be described in terms of another regression function,
- Uosm 250 (PAVP —0.25), where Uosm represents
-
urine osmolality in mOsm/kg and PAVP again repre-
sents plasma vasopressin concentration in pg/mI.
- The slope of this line indicates that for each unit
- increment in plasma vasopressin concentration above
-
the threshold level, urine osmolality rises by an aver-
age of 250 mOsm/kg. Thus, the full range of renal
-
concentrating and diluting capacity is covered by a
- ten-fold change in plasma vasopressin concentration,
- from 0.5 to 5 pg/mI. This dose-response range is
-
comparable to previous observations showing that
minimum and maximum antidiuresis in man result
- from the infusion of vasopressin at a rate of 0.2 and
- 2.9 iU/rnin/kg, respectively [151. Coupling this sen-
-
sitive concentrating mechanism to an equally sensi-
tive osmoregulatory property of vasopressin secre-
tion provides a system by which small changes in
310 plasma osmolality are rapidly translated into rela-
tively large changes in urine osmolality. This prop-
erty, which may be referred to as the "gain" of the
system, can be estimated by substituting the re-
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gression equation derived from Fig. I (PAVP =
0.35 . zPosm) into that derived from Fig. 2 (zUosm
= 250 ZPAVP) to give the formula zUosm = 250 X
0.35 zPosm or zUosm = 95 Posm. This means
that, within certain limits set by the threshold of the
osmoreceptor on one side and the maximum con-
centrating capacity of the kidney on the other, a
change in plasma osmolality of 1 mOsm/kg normally
leads to a change in urine osmolality averaging 95
mOsm/kg, a gain of almost 100-fold.
This characteristic of the system is extremely im-
portant in enabling the organism to maintain body
water very constant by rapidly altering urine output
to compensate for variations in water intake. As
shown in Fig. 3, basal plasma osmolality in healthy
adults normally averages 287 mOsm/kg. This results
in a plasma vasopressin level between 2 and 2.5
pg/ml, which is near the middle of the dose-response
range of the renal concentrating mechanism. From
this position, srr all alterations in water balance in
either direction are able to elicit rapid compensatory
adjustments in urine concentration and flow. For
example, an increase in total body water of only 1%
would be expected to decrease plasma osmolality by
2.9 mOsm/kg, reduce plasma vasopressin and urine
osmolality by almost 50% and double the rate of
urine output. An increase in total body water only
twice as great would be sufficient to reduce plasma
osmolality and vasopressin virtually to threshold lev-
els (281.3 mOsm/kg and 0.5 pg/mI, respectively) thus
permitting maximum urinary dilution to occur. This
state of affairs is of special physiological significance
because the increase in the rate of urine flow thus
achieved normally equals or exceeds the rate at which
free water can be ingested on a sustained basis.1
For practical purposes, therefore, a greater in-
crease in body water cannot be maintained and
plasma osmolality will stabilize at a new level whose
lower limit is determined by the threshold or "set-
point" of the osmoreceptor mechanism. Reductions
in total body water have an equal but opposite effect
on plasma vasopressin and urine osmolality with the
maximum antidiuretic response being obtained at a
plasma osmolality of about 294 mOsm/kg, an in-
crease of only slightly more than 2%. Interestingly,
this is also the level of plasma osmolality at which
healthy adults first report a conscious desire to drink
(Robertson GL, Athar S: unpublished observations),
'This does not apply to situations in which solute excretion or
certain other aspects of renal function are impaired. because the
rate of maximum free water excretion under these conditions may
be drastically reduced even when vasopressin is fully suppressed
[12,16] or even totally absent [17].
Fig. 3. Schematic representation of the effect of small alterations in
basal plasma osmolality on plasma vasopressin and urine osmolality
in healthy adults.
indicating that the osmoreceptor for thirst normally
is set so as to provide backup protection against
inordinate decreases in body water that exceed the
compensatory capacity of the antidiuretic system. In
this way, the tonicity of body water ordinarily is
preserved within a relatively narrow range whose
boundaries are defined by the threshold of thirst os-
moreceptor above and by the threshold of the vaso-
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pressin osmoreceptor below. Between these two lim-
its, which ordinarily extend only from about 280 to
294 mOsm/kg, body tonicity is regulated more pre-
cisely still by small compensatory adjustments in free
water excretion brought about largely by os-
moreceptor mediated gradations in vasopressin secre-
tion. As discussed in later sections, each of the
elements in this regulatory system is subject to
physiologic or pathologic modifications that can re-
suit in a number of clinically distinct disturbances in
salt and water balance.
The extraordinary sensitivity of the osmoreceptor
controlling vasopressin secretion creates a number of
special problems which should be kept in mind when
performing and interpreting studies in this area. For
example, it is apparent that the capacity of the
osmoreceptor mechanism to sense and respond
to changes in plasma osmolality is normally greater
than the accuracy and precision with which this vari-
able can be measured in the laboratory. Even under
the best of conditions, conventional clinical osmom-
eters cannot achieve a reproducibility better than
mOsm/kg and a change in plasma osmolality
of this magnitude could alter urine osmolality by as
much as 100 mOsm/kg. In many experimental situa-
tions, such as water diuresis often used for indirect
studies of vasopressin release, this kind of change
could have profound effects and, if unrecognized,
lead to errors of interpretation. To minimize this
problem, therefore, measurements of plasma os-
molality should always be made with special care
using only the most sensitive, stable and well cali-
brated instruments available. It is also desirable that
such measurements be performed on plasma since the
conditions involved in preparing serum can result in
artefactual elevations in osmolality of as much as 10
mOsm/kg [18], a very large amount relative to the
physiologic considerations involved, Even larger ar-
tefacts, up to 20 mOsm/kg, can be produced by the
injudicious use of tourniquets, so that whenever pos-
sible, blood for osmolality measurements also should
be drawn without stasis. Most routine clinical deter-
minations of blood osmolality fail to satisfy one or
more of these requirements and consequently tend to
be of limited value in diagnosing most disorders of
vasopressin function (vide infra).
It is important to note that the functional charac-
teristics of the osmoregulatory systems in healthy
adults exhibit considerable individual variation and
may differ appreciably from the mean normal values
described above. Regression analyses of the data ob-
tained from each of 16 recumbent subjects during
hypertonic saline infusion reveal slopes that range
from 0.14 to 0.98 and thresholds from 276 to 291
mOsm/kg (Table 1). These individual regression func-
tions tend to be associated with relatively high corre-
lation coefficients, to be reproducible on repeat test-
ing and, when averaged, to give values closely ap-
proximating those derived from pooled data (Fig,
1) [3,10]. Thus, the wide scatter that characterizes the
relationship between plasma vasopressin and os-
molality in a population of healthy adults (Fig. 1)
appears to be due largely to individual differences
in osmoreceptor threshold and/or sensitivity rather
than to a lack of stability or precision in its response
characteristics. The reason for these apparently in-
herent differences in osmoreceptor function is un-
known. They do not seem to be effected by the sex of
the individual (Table 1) and, although aging does
seem to alter the slope or sensitivity of the response
[19], other factors also must be involved since the
subjects in Table 1 were of similar age. Changes
in hemodynamic factors also can influence osmo-
receptor function (vide infra) but probably con-
tribute little to individual variability because these
functional differences are too great to be accounted
for by ordinary variations in blood volume [10,19,20]
and show no correlation with individual differences
in resting arterial pressure. Genetic influences may
play some role in the set of the osmoreceptor since
groups of rats from the same strain demonstrate a
remarkably constant threshold value well above that
found in man [13].
Besides threshold and sensitivity, two other func-
tional characteristics of the osmoreceptor mechanism
also can significantly influence the relationship be-
Table 1. The relation
in each of 16 normal
ship of plasma
subjects during
AVP to plasma osmolality
hypertonic saline infusions
Subject Sex
Correlation
coefficient Intercept Slope
I M 0.64 276 0.15
2 F 0.70 281 0.23
3 M 0.82 279 0.17
4 F 0.92 283 0.26
5 F 1.00 276 0.14
6 M 0.87 277 0.15
7 M 0.77 284 0.98
8 M 0.73 279 0.36
9 M 0.90 282 0.31
10 M 0.85 285 0.42
II F 0.81 283 0.16
12 F 0,94 283 0.51
13 F 0.91 282 0.39
14 M 0.95 284 0.39
15 F 0.96 281 0.68
16 M 0.94 291 0.85
Mean (±so) 0.85 0.10 281 3.8 0.38
(±sE) 0.03 0.9 0.06
Each regression function was calculated on a minimum of 8
value pairs. (Robertson GL, Athar S, Shelton RL: unpublished
observations)
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tween plasma vasopressin and plasma osmolality
[11]. For one, the sensitivity of the mechanism ap-
pears to be at least partially rate-dependent—i.e., the
magnitude of the hormonal response to a given stim-
ulus will depend not only on the absolute level of
blood osmolality achieved but also on the rate of
change. As shown in Fig. 4, this effect is usually not
apparent when plasma osmolality is increased at a
rate of 2%/hr or less, but becomes quite pronounced
when the rate of change in osmolality even slightly
exceeds this limit. When that happens, the rise in
plasma vasopressin per unit increment in plasma os-
molality appears to be exaggerated by an amount
roughly proportional to the fractional increase in the
stimulation rate. However, once the stimulus is re-
moved and plasma osmolality ceases to rise, plasma
vasopressin gradually declines to a new, more stable
level comparable to that seen when the same level of
osmolality is achieved under slower, rate-independ-
ent conditions of stimulation.
The basis for the rate-dependent aspect of os-
moregulatory sensitivity is still unknown. To some
extent, the exaggerated rise in plasma vasopressin
may simply reflect the time required for rapidly se-
creted hormone to equilibrate completely throughout
its distribution space. This cannot be the only mecha-
nism, however, because other studies with exogenous
vasopressin indicate that such mixing is normally
complete within 10 to 15 minutes [21], and the decline
observed here required much longer to complete.
This indicates that a change in secretion rates also
must be involved and that the response character-
istics of the osmoreceptor therefore must differ with
different rates of stimulation. This could occur, for
example, if the mechanism normally adapts to hyper-
osmolality by making a limited desensitizing adjust-
ment requiring a finite period of time to complete.
Whatever its basis, this rate dependency has several
immediate and practical consequences for studies of
osmoreceptor function. For example, when attempt-
ing to determine the effect of a given condition on
osmotically mediated vasopressin secretion, it is most
desirable to conduct the experiments under rate-inde-
pendent conditions—i.e., with stimuli that increase
osmolality at a rate of less than 2%/hr. In this way, if
small variations in stimulation rate occur, they will
not significantly affect the response and the regression
functions can be compared directly without biasing
the results. If slow rates of stimulation are not pos-
sible, meaningful comparisons may still be made but
only if the rate of change in osmolality is shown to be
identical under each experimental condition. For the
same reason, it is equally important that the osmotic
stimulus be applied in a smooth and even manner—
Fig. 4. Schematic representation of the effect of varying the rate of
hypertonic saline infusion on the change in plasma vasopressin con-
centration in healthy adults. At each rate, (0.06, 0.1, and 0.16
mi/kg/mm) the total volume of saline infused was constant. The
numbers juxtaposed to the lines in the lower panel indicate the
overall rate of change in plasma osmolality, expressed as %/hr,
during each of the infusions; in the upper panel, the numbers
indicate the slope or regression coefficient of the relationship be-
tween plasma vasopressin and osmolality during the same infusions
(Robertson GL, Athar S: unpublished observations).
i.e., that the moment-to-moment as well as the over-
all rate of change be kept constant. Otherwise, the
response characteristics of the osmoreceptor also will
appear to change from moment to moment and the
erratic changes in plasma vasopressin that result will
yield a regression function seriously distorted in
terms of correlation and intercept as well as slope.
Because of this, it is desirable in studies of vasopres-
sin function to use some kind of mechanical control,
such as an infusion pump, when administering hyper-
tonic test solutions by the intravascular route.
The relationship between plasma vasopressin and
osmolality also may be influenced markedly by the
kind of blood solutes present. Under normal condi-
tions, sodium and its associated anions contribute
more than 95% of the osmotically active constituents
of plasma, and it is changes in the concentration of
these ions that are largely, if not totally, responsible
for mediating the osmoregulatory response to phys-
iologic changes in free water balance. However, these
are not the only blood solutes capable of stimulating
vasopressin secretion since an infusion of hypertonic
mannitol, which raises plasma osmolality and lowers
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serum sodium concentration, also produces a rise
in plasma vasopressin that is quantitatively in-
distinguishable, unit for unit, from that produced by
an infusion of hypertonic saline (Fig. 5). Thus, as
Verney correctly concluded from his indirect studies
[l}, the mechanism controlling vasopressin secretion
is able to respond to different kinds of blood solutes
as though it were a true osmoreceptor rather than a
specific sodium receptor. However, as Verney also
recognized [1], not all solutes are equally effective in
this regard. In fact, when plasma osmolality is raised
by a rapid infusion of hypertonic glucose, plasma
vasopressin is significantly depressed rather than
stimulated (Fig. 5) [11]. This effect, which would
have been indiscernible under the water loaded con-
ditions employed in Verney's studies, indicates that
certain blood solutes are not only unable to stimulate
the osmoreceptor but, perhaps through their ability
to lower the concentration of effective solutes such as
sodium, actually can exert a paradoxical, suppressive
effect. It also suggests that the polyuria which accom-
panies hyperglycemic conditions such as diabetes
mellitus sometimes may be due not only to a solute
diuresis but also to suppression of vasopressin secre-
tion.
The basis for this selectivity in osmoreceptor re-
sponse is not firmly established but appears to be
related to the rates at which the different blood so-
lutes are able to penetrate the blood-brain barrier
285 295 305 315
Plasma osmolality,
mOsm/kg
Fig. 5. Schematic representation of the relationship between plasma
vasopressin and plasma osmola/ity in healthy adults during the in-
fusion of hypertonic saline, mannitol or glucose. In each case, the
rates of change in osmolality and expansion of blood volume were
the same (Robertson GL, Athar S: unpublished observations).
[22]. Thus, sodium and mannitol, which penetrate
very slowly, are equally potent in their ability to
stimulate vasopressin release, while glucose, which
penetrates very rapidly, does not have this effect.
Preliminary studies with hypertonic urea, which pen-
etrates at an intermediate rate and appears to have
very little effect on plasma vasopressin (Kinney RL,
Robertson GL: unpublished observations) would
seem to fit this pattern. Precisely how the estab-
lishment of an osmotic gradient across the blood-
brain barrier plays an integral role in the os-
moregulatory response is unclear, but it may do so by
producing shifts in water and extracellular solute
concentration in the vicinity of the hypothalamic os-
moreceptor.
The fact that the osmoreceptor is capable of re-
sponding to several but not all blood solutes has
certain advantages as well as disadvantages for those
interested in studying vasopressin regulation. On the
positive side, it means that hypertonic mannitol may
be used in place of saline to evaluate osmoregulatory
function in clinical conditions such as congestive fail-
ure or nephrosis where the administration of a large
sodium load might be contraindicated. On the nega-
tive side, it means that neither plasma osmolality
nor sodium concentration can be relied upon to pro-
vide a universally valid reference point for determin-
ing the functional state of the osmoreceptor mechan-
ism. The kind of approach depicted in Fig. 1 obviously
is useful only when blood glucose and urea are nor-
mal, since elevations in either solute will grossly dis-
tort the usual relationship between plasma vasopressin
and osmolality (Fig. 5). Even relatively modest changes
in blood glucose can sometimes cause problems of
interpretation because by producing reciprocal
changes in plasma sodium (I mEq/liter for each 2
mM/liter change in glucose) they can alter the ef-
fective level of osmoreceptor stimulation without
significantly altering the total solute content of
plasma. Measurements of plasma sodium do not
provide a totally satisfactory solution to this di-
lemma because, as usually performed, they are less
precise even than those for osmolality and, as a
result, may introduce problems of another type (vide
supra). Also, there may be other naturally occurring
blood solutes, such as glycerol or lactate, that can
effect the osmoregulation of vasopressin in certain
situations. For these reasons, plasma osmolality is
probably still the best reference point for most
studies of vasopressin function, although, depend-
ing on experimental conditions and objectives,
changes in plasma sodium and other solutes also
may need to be monitored.
Physiologic alterations in osmoregulation of vaso-
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pressin. Although the functional characteristics of the
osmoreceptor in a healthy individual appear to be
relatively stable, they may be modified in specific
ways by changes in blood volume and pressure
[10,13,23] as well as, perhaps, by aging [24]. Within
physiologic limits, these changes do not seem to di-
minish the precision or degree of control of the os-
moreceptor, but merely to shift the set point or ap-
parent sensitivity of the mechanism in such a way as
to counteract the kind of disturbance with which it is
associated.
For example, reducing blood volume beyond a
certain point has been shown to lower the threshold
of the osmoreceptor in both rats [13] and man (Table
2). Since the magnitude of this effect is a curvilinear
function of the degree of hypovolemia present [13],
the "set" of the osmoreceptor appears to change
relatively little until blood volume declines by a sub-
stantial amount—about 10% in rats [13] and between
7 and 15% in man [l0,19,20]—but after that resets to
progressively lower levels as blood volume is further
reduced. This resetting of the vasopressin osmo-
receptor may be accompanied by a comparable
reduction in the osmotic threshold for thirst [25],
again suggesting the existence of a close functional
link between these two mechanisms for regulating
water balance. The ultimate effect of this kind of
adjustment in osmoreceptor function is to facilitate a
limited increase in free water retention, thereby
lowering the tonicity of body water by a controlled
amount and partly correcting the volume deficit. The
effects of hypervolemia and/or hypertension on os-
moreceptor function have not been as well defined,
but seem to entail a series of changes in osmoreceptor
function and free water balance opposite to those
produced by hypovolemia (Table 2) [14]. As a con-
sequence of this kind of interaction, the functional
characteristics of the osmoregulatory system can be
thought of in terms of a family of lines whose exact
position or "set" will vary depending on the state of
the blood volume or pressure (Fig. 6). The slope or
Table 2. The relationship of plasma AVP to plasma osmolality
in 18 healthy adults under different experimental conditions
Condition
Correlation
coefficient
Regression
equation Difference
Hydropenia,
upright
.
Hydropenia,
0.44 y = 0.31(x
—277.8).
")P< 0.05
recumbent 0.54 y = 0.35(x —281.0
.
Hypertonic saline,
<0,05
recumbent 0.62 y = 0.32(x —281.8
y = plasma AVP (pg/mI) x = plasma osmolality (mOsm/kg)
Fig. 6. Schematic representation of the relationship between blood
volume or pressure and the functional characteristics of the os-
moreceptor controlling vasopressin secretion. The numbers inside
the circles indicate the magnitude of the hemodynamic change
required to effect the shift in the corresponding regression line [10,
13, 14].
sensitivity of the osmotic response also may be effec-
ted by hemodynamic factors [13], but this kind of
change is not seen invariably [10,23] and may be due
at least in part to changes in the volume of distribu-
tion of vasopressin [21] rather than in the amount of
hormone released per unit increment in osmolality.
The way in which hemodynamic variables effect
this change in osmoregulatory function is not well
understood as yet. It seems clear that neurogenic
afferents from pressure or volume sensitive receptors
in the heart and large arteries of the chest and neck
are an integral part of this response, but the central
loci where such impulses are integrated and propa-
gated to the neurohypophysis and the final neuro-
chemical events by which they modify the osmo-
receptor control of vasopressin secretion are still
unknown. Such information may prove to be of some
practical value, because it is possible that certain
clinical disordGrs of vasopressin regulation result
from aberrant or inappropriate signals from the
hemodynamic control system (vide infra) and, thus,
might be treatable with drugs that can alter neuro-
chemical function. It also will be important to deter-
mine whether chronic changes in blood volume or
pressure are associated with comparable changes in
osmoreceptor function since many hemodynamic
receptors and reflexes appear to have the capacity
to adapt to long-standing disturbances of this kind.
The existence of this kind of interaction between
the osmotic and hemodynamic controls of vasopres-
sin provides a more rational basis from which to
consider certain clinical disturbances of salt and wa-
ter balance. It indicates that a condition in which the
tonicity of body fluids appears to be "reset" could
result not only from a primary disturbance in os-
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moreceptor function (vide infra) but also secondarily
from any disease that interferes substantially with the
normal control of blood volume or pressure. This
might explain why both hepatic and cardiac failure,
in which either total or effective blood volume may be
reduced, sometimes appear to be associated with re-
setting of the osmoregulatory system to subnormal
levels [26,27]. Other hypovolemic or hypotensive
conditions such as those resulting from diuretic abuse
or mineralocorticoid deficiency also may be shown
eventually to be associated with similar reductions in
the set of the osmoregulatory system. Whether there
are clinical counterparts in which hypervolemia or
hypertension abnormally elevate the tonicity of body
fluids is unclear, but the hypernatremia character-
istically seen in patients with primary hyperaldoste-
ronism [28] could be the manifestation of such an
effect.
Because the osmoreceptor control of vasopressin is
qualitatively unimpaired by changes in blood volume
or pressure, osmotic variables cannot be ignored
when evaluating the hormonal response to non-os-
motic stimuli. As can be seen from Fig. 6, a 10%
reduction in blood pressure would produce a very
impressive rise in plasma vasopressin under isotonic
conditions, but no response if, simultaneously, the
concentration of total or effective blood solutes were
to decline by as little as 1.8% (5 mOsm/kg). Consid-
ering that a fall in plasma sodium of this magnitude
could easily result from a stress-induced rise in
plasma glucose of only 90 mg/lOO ml, it is easy to
appreciate how complex and difficult the proper in-
terpretation of vasopressin studies may sometimes
be.
Normal aging is associated with a significant in-
crease in the plasma vasopressin response to hyper-
tonic saline infusion [24]. Unlike the change pro-
duced by hemodynamic variables, the effect of age
appears to be due solely to an increase in the slope or
sensitivity of the response rather than to a change in
the threshold or set of the osmoreceptor mechanism.
It has not yet been determined whether this result is
due to a true increase in osmoreceptor sensitivity, to
an increase in the quantity of vasopressin available
for release, or to a decrease in the volume of distribu-
tion and/or peripheral metabolism of the hormone.
Whatever the mechanism, however, it is important to
recognize that this apparent increase in sensitivity
necessitates the use of age-adjusted normal values for
plasma vasopressin and can significantly alter the
normal response to certain traditional kinds of phar-
macologic suppression [29].
Indirect studies have suggested that the osmotic
threshold for vasopressin also may be increased
slightly by sypraphysiologic doses of cortisol [30]. It
has not been determined whether this is secondary to
other effects of the hormone, such as increases in
plasma glucose, blood volume or blood pressure, or
to a direct effect of cortisol on osmoreceptor func-
tion.
Pathological alterations in the osmoregulation of
vasopressin. Many disorders of water metabolism
seen clinically now can be readily characterized in
terms of a specific disturbance in one or more aspects
of the normal osmoregulatory system.
The vasopressin deficiency characteristic of ac-
quired pituitary diabetes insipidus behaves almost
uniformly as though it were due to a marked reduc-
tion in the sensitivity or gain of the osmoreceptor
mechanism. Plasma vasopressin in these patients
tends to be low but detectable and usually increases,
often to physiologically effective levels, when water
intake is restricted (Fig. I). However, the increase in
vasopressin thus achieved is invariably subnormal
relative to the degree of hypertonic dehydration pro-
duced, so that when these values are subjected to
regression analysis, a significant positive correlation(r = 0.42; P < 0.01) is still present, but the slope of
the resultant regression function, PAVP = 0.03 (Posm
— 275), is reduced to less than 1/10 the normal value.
This result, which suggests a selective impairment in
the sensitivity or gain of the osmoreceptor system, is
corroborated by the regression functions obtained in
individual patients during hypertonic saline infusion
(Table 3).
It now seems clear that this kind of decrease in
osmotically mediated vasopressin secretion can occur
in at least two ways. Probably the most common and
widely recognized cause is a reduction in the amount
of vasopressin available for secretion due to injury or
destruction of the neurohypophysis. Such cases clas-
sically result from surgical hypophysectomy and, as
might be expected, generally exhibit quantitatively
similar reductions in their vasopressin response to
hemodynamic and osmotic stimuli (Shelton RL,
Robertson GL: unpublished observations). Consid-
Table 3. The relationship of plasma vasopressin to plasma
osmolality during hypertonic saline infusion in six
patients with pituitary diabetes insipidusa
Patient Etiology
Correlation
coefficient Intercept Slope
I
2
3
4
5
6
Idiopathic
Idiopathic
Idiopathic
Idiopathic
Idiopathic
Hypophysectomy
0.92 290
0.68 270
0.60 280
0.96 289
No response
No response
0.05
0.02
0.06
0.06
Robertson GL, Athar 5, Shelton RL: observations
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ering the extent to which the response to dehydration
is reduced in these patients, more than 90% of the
normal secretory stores of vasopressin apparently
must be eliminated for the disorder to manifest clini-
cally. Less commonly, the same kind of regulatory
defect can result from a lesion which selectively im-
pairs osmoreceptor function without diminishing the
neurosecretory stores of vasopressin or the response
to non-osmotic stimuli [31,33]. These uncommon
patients, who usually present with signs and symp-
toms atypical of diabetes insipidus (vide infra), con-
stitute an important experiment of nature because
they demonstrate conclusively that the osmoreceptor
mechanism in man is anatomically separate from the
neurohypophysis and also is not an integral part of
the neurogenic pathway by which hemodynamic vari-
ables exert their effect on vasopressin. In these pa-
tients, hypertonic dehydration also elicits a markedly
subnormal rise in plasma vasopressin, presumably
because the response must be mediated solely by the
much less sensitive volume-dependent pathways [13].
The demonstration of this kind of relative os-
moregulatory deficiency in diabetes insipidus helps to
simplify our understanding of the various ways in
which the disorder can behave clinically. It makes
clear, for example, that the degree of polyuria exhib-
ited by a given patient will be determined not only by
the extent to which osmotically mediated vasopressin
secretion is diminished, but also by the degree to
which the mechanisms for maintaining water intake
are preserved. In an uncomplicated case in which
water intake is not impaired, basal plasma osmolality
would not be allowed to rise spontaneously much
above the normal thirst threshold of 294 mOsm/kg.
Assuming a 90% or greater reduction in the vasopres-
sin response, holding plasma osmolality at this level
would result in mean basal plasma vasopressin and
urine osmolality values of only 0.6 pg/mI and 90
mOsm/kg, respectively (Figs. 1 and 2) and lead to
marked polyuria of approximately ten liters a day.
However, if, as may happen, the nearby osmo-
receptor controlling thirst also were damaged to
some degree, then water intake would not be stimu-
lated sufficiently to keep up with losses and, as a
result, basal ftasma osmolality would rise sponta-
neously to a higher level. This would permit a small
but significant increase in basal plasma vasopressin
and urine osmolality and a relatively large decrease in
daily urine output. In an occasional patient, the loss
of thirst can be so complete that the degree of hyper-
tonic dehydration tolerated under basal conditions
will be sufficient to force up plasma vasopressin and
urine osmolality to normal levels, thus abolishing
polyuria and polydipsia completely (3 1—34]. In cases
such as this, the only presenting sign may be unex-
plained hypernatremia, and the underlying defect in
vasopressin function will not become apparent until
an effort is made to restore hydration to normal.
This combination of blunted thirst and vasopressin
responsiveness to osmotic stimulation also accounts
for the tendency of many of the patients to exhibit
relatively large day to day variations in water balance
[31]. These fluctuations occur not only because drink-
ing is less well regulated, but also because the capac-
ity of the excretory system to respond to these varia-
tions in water intake is greatly reduced. Since the
renal sensitivity to vasopressin appears to be un-
changed (Fig. 2), the overall "gain" of the os-
moregulatory system will be reduced in proportion to
the decrease in the slope of the regression line relating
plasma vasopressin to osmolality. On the average,
therefore, the change in urine osmolality and flow
evoked by a given change in plasma osmolality in a
patient with diabetes insipidus will be approximately
ten-fold less than in a healthy adult. Consequently,
uncontrolled increases as well as decreases in water
intake may be counteracted much less rapidly and
completely by the kidney and will lead to correspond-
ingly greater and more sustained fluctuations in free
water balance and plasma osmolality.
The relative nature of the vasopressin deficiency in
diabetes insipidus also underscores some of the limi-
tations of the diagnostic criteria traditionally used to
differentiate this disorder from other causes of poly-
uria. Since a decrease in osmotically mediated vaso-
pressin secretion is the sine qua non of pituitary diabe-
tes insipidus and need not be accompanied by
impaired responsiveness to other kinds of stimuli,
tests which involve the latter are of limited and uncer-
tain diagnostic value. This applies not only to pro-
cedures such as the nicotine stimulation test, whose
limitations have been recognized for many years [35],
but to any clinical maneuver which induces emesis
(Helderman JH, Vestal RE, Rowe JW, Tobin JD,
Andres R, Shelton RL, Robertson GL: unpublished
observations) or hypotension [3,32,34], both potent
stimuli to vasopressin secretion. Even those tests
which rely predominantly on osmotic stimulation,
such as hypertonic saline infusion [36] or water depri-
vation [37], can be diagnostically misleading if the
intensity of the stimulus and individual variability in
the set of the osmoreceptor mechanisms are not taken
into account. Because the deficiency of vasopressin in
acquired diabetes insipidus is relative rather than ab-
solute, the degree of antidiuresis that can be achieved
usually is limited only by the patient's tolerance for
thirst and, in many, nearly normal levels of plasma
vasopressin (Fig. 1; Table 2) or urine osmolality
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[37—39] can be achieved without undue discomfort.
In most cases, however, urinary concentration will
not occur until plasma osmolality exceeds the level at
which healthy adults uniformly exhibit a maximum
antidiuresis (294 mOsm/kg). Therefore, if the results
are considered in relation to the degree of hypertonic-
ity present, the deficiency of vasopressin secretion
usually can be clearly recognized. However, probably
because of individual variation in the set of the os-
moregulatory system (Table I), some patients with
well documented diabetes insipidus will show a good
antidiuretic response before plasma osmolality reaches
294 mOsm/kg. This diagnostic dilemma almost al-
ways can be resolved by measuring vasopressin
sequentially during prolonged water deprivation or
hypertonic saline infusion since in patients with pri-
mary polydipsia the slope or sensitivity of the vaso-
pressin response is normal (Fig. 1). In nephrogenic
diabetes insipidus, the osmoregulation of vasopressin
also is normal (Fig. I) and the polyuria is due simply
to impaired renal responsiveness to the hormone
(Fig. 2). The presence of relatively normal vasopres-
sin function in primary polydipsia and nephrogenic
diabetes insipidus indicates that, unlike some other
endocrine systems, neither chronic suppression nor
stimulation significantly alters the functional prop-
erties of the neurohypophysis. This greatly simplifies
the diagnostic use of vasopressin assays in these dis-
orders and, in most cases, the etiology of the polyuria
can be established simply by obtaining a simultaneous
measurement of plasma vasopressin, plasma osmolal-
ity and urine osmolality under recumbent, dehydrated
conditions.
A primary resetting of the osmoregulatory system
to abnormally high levels has been proposed as the
etiology of certain cases of chronic hypernatremia
[40]. Some evidence supporting the existence of such
an entity has been reported, but it is all based on
indirect studies of vasopressin function and, as em-
phasized in a recent critique [41], may have been
misinterpreted because the regression methods neces-
sary to distinguish between real and apparent shifts in
osmoreceptor threshold were not used. It is also im-
portant to recognize that, because the vasopressin
response to blood volume depletion follows a curvilin-
ear pattern [13], a patient in whom osmoreceptor
function has been completely but selectively ablated
[34] might respond to the hypovolemic effect of pro-
longed fluid deprivation as though his osmoreceptor
had been reset to a much higher level. To avoid this
problem, osmoreceptor function in these patients al-
ways should be characterized with a stimulus, such as
hypertonic saline infusion, which does not reduce
blood volume. None of the patients already studied
in this way have exhibited an elevated osmotic thresh-
old for vasopressin release [32—34,41], so the exis-
tence of such an entity still is conjectural.
Clinical disorders resulting from an increase in wa-
ter retention also can be usefully characterized in
terms of specific defects in normal osmoregulatory
function. The conclusion, originally advanced by
Bartter [42] and by Schwartz, that the syndrome of
inappropriate antidiuretic hormone secretion (SIADH)
results from an inability to normally suppress vaso-
pressin secretion now has been largely confirmed
by both bioassay [43,44] and immunoassay [7,45,46]
studies. Most of the time, however, the levels of
vasopressin that circulate in these patients are
within the range customarily found in normally
hydrated healthy adults and can be recognized as
abnormal only in relation to the hypotonicity
present. Just as in the polyuric conditions, there-
fore, measurements of plasma vasopressin in SIADH
have little diagnostic value unless obtained in con-
junction with measurements of plasma osmolality
when the patient is abnormally hydrated.
It is also important to recognize, however, that the
inability to normally suppress vasopressin can result
from more than one kind of regulatory defect and, as
a consequence, may not always exhibit exactly the
same clinical and laboratory characteristics. Sequen-
tial measurements of plasma vasopressin in SIADH
patients receiving therapeutic infusions of hypertonic
saline reveal several distinct types of abnormal re-
sponse (Fig. 7). Type A, which seems to be present in
approximately 20% of these patients, is characterized
by large erratic changes in plasma vasopressin which
show no relationship whatsoever to the rise in plasma
osmolality. This pattern, which has been observed in
association with non-tumorous as well as tumorous
diseases, indicates that vasopressin release has been
completely divorced from osmoreceptor control and
is occurring either at random or in response to tran-
sient and erratic, non-osmotic stimuli. Because so
many patients with SIADH exhibit this kind of be-
havior, one or two measurements of vasopressin are
never sufficient to give a reliable picutre either of the
kind of defect present or of its responsiveness to a
particular experimental maneuver.
Type B, which is found in about 35% of these
patients, is characterized by prompt and progressive
increases in plasma vasopressin which correlate
closely with the rise in plasma osmolality (Fig. 7). In
each of these patients, the regression line describing
this relationship has a slope that parallels the normal
response but that intercepts the osmolality axis well
below 275 mOsm/kg, the lowest level found in
healthy adults. This pattern, which has been observed
in association with a wide variety of diseases, in-
dicates that the osmotic control of vasopressin secre-
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tion is qualitatively normal but that the threshold of
the receptor has been reduced to abnormally low
levels. The mechanism by which this resetting of the
osmoreceptor occurs is still unknown but, in view of
the frequency and diversity of clinical settings in
which it occurs, may represent the final common
result of several different pathogenetic processes. Re-
ductions in blood volume and/or pressure produce a
similar kind of change (Fig. 6), but cannot play a role
in these patients since, by definition, clinically appar-
ent hypovolemia or hypotension is not present in
SIADH, and the shifts observed here are too large to
result from subclinical reductions in either variable.
However, the same kind of resetting might result
from false hemodynamic signals, such as those gener-
ated by neuropathic lesions in the afferent limb of the
volume and/or baroreceptor system [46], or from a
totally unrelated disturbance such as a reduction in
the osmotic "stuffing" of osmoreceptor neurons [47].
Regardless of the etiology, however, patients with
this kind of defect might be expected to exhibit cer-
tain clinical characteristics not seen in the other types
of SIADH. Because the osmotic control of vasopres-
sin is qualitatively normal, increasing water intake
should lead eventually to maximum urinary dilution
and, from that, a rate of output sufficient to prevent
further increases in water balance. DeFronzo, Gold-
berg and Agus and Michelis et al recently have
described several patients who exhibit precisely this
behavior [48,49] and quite probably are examples
of this kind of osmoregulatory defect.
Type C, also found in about 35% of our patients, is
characterized by plasma vasopressin levels that are
elevated initially but do not change significantly until
plasma osmolality passes the normal threshold level,
at which point they begin to rise appropriately in
response to further increases in tonicity (Fig. 7). This
pattern, which has been observed in several patients
with meningitis and/or basilar skull fractures but
also occurs in association with other diseases, in-
dicates that there is a constant, nonsuppressible re-
lease or "leak" of vasopressin under hypotonic con-
ditions despite otherwise normal osmoreceptor
function. Unlike those with the type B defect, these
patients would be expected to exhibit the findings
typical of SIADH at all times, since maximum
urinary dilution should never occur regardless of how
severe the water retention and resultant hypotonicity
became.
Type D, found in about 10% of our patients, is
characterized by plasma vasopressin levels which
seem to be normally suppressed under hypotonic
conditions and also do not rise until plasma os-
molality exceeds the normal threshold level (Fig. 7).
This interesting and unusual pattern is associated
Fig. 7. The relationship of plasma vasopressin to osmolality during
hypertonic saline infusion in four patients with the clinical syndrome
of inappropriate antidiuresis (Robertson GL, Athar S, Shelton
RL: unpublished observations).
with continuous production of a concentrated urine,
suggesting that the diluting defect is not due to ab-
normal secretion of vasopressin but to some other
factor, such as a change in the renal sensitivity to the
hormone or the elaboration of some other as yet
unrecognized antidiuretic substance.
Summary
The secretion of vasopressin normally is controlled
by a very sensitive and precise osmoreceptor whose
functional properties are normally quite stable but
can be modified in specific and physiologically appro-
priate ways by moderate changes in blood .volume or
pressure. This osmoreceptor seems to be located in
the anterior hypothalamus near the thirst center but
appears to be separate, at least in part, from the
axons and cell bodies which form the neurohy-
pophysis. Its response to stimulation may be in-
fluenced not only by the absolute levels of blood
osmolality achieved but also by the rate of change
and the particular kind of blood solutes involved.
Because of this and its extraordinary sensitivity, a
number of special precautions must be employed
when undertaking studies of vasopressin secretion.
Specific physiologic or pathologic alterations in the
functional properties of the osmoreceptors con-
trolling vasopressin secretion and/or thirst result in a
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variety of disorders in salt and water balance with
distinct and well recognized clinical characteristics.
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